Asset Management
Build Your Comparison
Side-by-side financial analysisStock Comparison
SAR vs PFLT vs JPM vs ARCC vs GAIN
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Banks - Diversified
Asset Management
Asset Management
SAR vs PFLT vs JPM vs ARCC vs GAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Banks - Diversified | Asset Management | Asset Management |
| Market Cap | $359M | $742M | $908.57B | $12.95B | $589M |
| Revenue (TTM) | $62.82B | $178M | $280.33B | $2.63B | $112M |
| Net Income (TTM) | $39M | $62M | $57.05B | $1.15B | $195M |
| Gross Margin | 0.1% | 49.8% | 60.0% | 70.8% | 57.9% |
| Operating Margin | -0.2% | 49.9% | 25.9% | 66.2% | 118.5% |
| Forward P/E | 8.9x | 6.9x | 14.6x | 9.4x | 36.4x |
| Total Debt | $293.33B | $1.78B | $942.38B | $15.99B | $564M |
| Cash & Equiv. | $22.32B | $123M | $343.34B | $924M | $1M |
SAR vs PFLT vs JPM vs ARCC vs GAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Saratoga Investment… (SAR) | 100 | 139.8 | +39.8% |
| PennantPark Floatin… (PFLT) | 100 | 89.0 | -11.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 345.8 | +245.8% |
| Ares Capital Corpor… (ARCC) | 100 | 124.8 | +24.8% |
| Gladstone Investmen… (GAIN) | 100 | 144.3 | +44.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SAR vs PFLT vs JPM vs ARCC vs GAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SAR has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.
- Dividend streak 5 yrs, beta 0.48, yield 100.0%
- Rev growth 1.3K%, EPS growth 14.4%
- PEG 0.75 vs GAIN's 1.21
- Beta 0.48, yield 100.0%, current ratio 0.08x
PFLT ranks third and is worth considering specifically for bank quality.
- NIM 5.0% vs JPM's 2.2%
- Lower P/E (6.9x vs 36.4x), PEG 0.78 vs 1.21
JPM is the clearest fit if your priority is long-term compounding.
- 481.2% 10Y total return vs GAIN's 272.1%
- +20.9% vs PFLT's -16.4%
ARCC is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.1% vs SAR's 0.7% (lower = leaner)
- Efficiency ratio 0.1% vs SAR's 0.7%
GAIN is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.47, Low D/E 84.5%, current ratio 0.01x
- Beta 0.47 vs JPM's 0.87, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.3K% NII/revenue growth vs GAIN's -20.5% | |
| Value | Lower P/E (6.9x vs 36.4x), PEG 0.78 vs 1.21 | |
| Quality / Margins | Efficiency ratio 0.1% vs SAR's 0.7% (lower = leaner) | |
| Stability / Safety | Beta 0.47 vs JPM's 0.87, lower leverage | |
| Dividends | 100.0% yield, 5-year raise streak, vs JPM's 1.8% | |
| Momentum (1Y) | +20.9% vs PFLT's -16.4% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs SAR's 0.7% |
SAR vs PFLT vs JPM vs ARCC vs GAIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
SAR vs PFLT vs JPM vs ARCC vs GAIN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GAIN leads in 1 of 6 categories
JPM leads 1 • SAR leads 0 • PFLT leads 0 • ARCC leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — PFLT and GAIN each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 2496.9x GAIN's $112M. GAIN is the more profitable business, keeping 173.6% of every revenue dollar as net income compared to SAR's 0.1%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $62.8B | $178M | $280.3B | $2.6B | $112M |
| EBITDAEarnings before interest/tax | $1.1B | $87M | $81.4B | $2.0B | $133M |
| Net IncomeAfter-tax profit | $39M | $62M | $57.0B | $1.1B | $195M |
| Free Cash FlowCash after capex | -$124.6B | $209M | $100.9B | $1.1B | $26M |
| Gross MarginGross profit ÷ Revenue | +0.1% | +49.8% | +60.0% | +70.8% | +57.9% |
| Operating MarginEBIT ÷ Revenue | -0.2% | +49.9% | +25.9% | +66.2% | +118.5% |
| Net MarginNet income ÷ Revenue | +0.1% | +34.8% | +20.4% | +43.7% | +173.6% |
| FCF MarginFCF ÷ Revenue | -198.4% | +117.4% | +36.0% | +43.5% | +23.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +13.1% | +20.3% | +16.0% | -63.9% | +3.2% |
Valuation Metrics
Evenly matched — PFLT and GAIN each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 3.1x trailing earnings, GAIN trades at a 81% valuation discount to JPM's 16.2x P/E. Adjusting for growth (PEG ratio), GAIN offers better value at 0.10x vs PFLT's 1.17x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $359M | $742M | $908.6B | $12.9B | $589M |
| Enterprise ValueMkt cap + debt − cash | $271.4B | $2.4B | $1.51T | $28.0B | $1.2B |
| Trailing P/EPrice ÷ TTM EPS | 9.56x | 10.39x | 16.22x | 9.69x | 3.10x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.90x | 6.93x | 14.60x | 9.41x | 36.40x |
| PEG RatioP/E ÷ EPS growth rate | 0.81x | 1.17x | 0.92x | 0.94x | 0.10x |
| EV / EBITDAEnterprise value multiple | — | 35.50x | 18.52x | 12.79x | 5.10x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 4.33x | 3.25x | 4.12x | 8.23x |
| Price / BookPrice ÷ Book value/share | — | 0.64x | 2.51x | 0.88x | 0.86x |
| Price / FCFMarket cap ÷ FCF | — | 7.81x | 9.01x | 11.34x | — |
Profitability & Efficiency
GAIN leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
GAIN delivers a 34.0% return on equity — every $100 of shareholder capital generates $34 in annual profit, vs $6 for PFLT. GAIN carries lower financial leverage with a 0.84x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), JPM scores 5/9 vs SAR's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +5.8% | +15.9% | +8.1% | +34.0% |
| ROA (TTM)Return on assets | +0.0% | +2.3% | +1.3% | +3.8% | +16.3% |
| ROICReturn on invested capital | -0.1% | +2.1% | +4.5% | +5.7% | +15.5% |
| ROCEReturn on capital employed | -0.3% | +2.7% | +8.9% | +7.5% | +25.3% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 4 | 5 | 4 | 4 |
| Debt / EquityFinancial leverage | — | 1.65x | 2.60x | 1.12x | 0.84x |
| Net DebtTotal debt minus cash | $271.0B | $1.7B | $599.0B | $15.1B | $563M |
| Cash & Equiv.Liquid assets | $22.3B | $123M | $343.3B | $924M | $1M |
| Total DebtShort + long-term debt | $293.3B | $1.8B | $942.4B | $16.0B | $564M |
| Interest CoverageEBIT ÷ Interest expense | -0.01x | 0.88x | 0.74x | 2.98x | 3.48x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $10,737 for PFLT. Over the past 12 months, JPM leads with a +20.9% total return vs PFLT's -16.4%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs PFLT's 1.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.8% | -14.1% | +0.8% | -7.1% | +8.9% |
| 1-Year ReturnPast 12 months | +4.2% | -16.4% | +20.9% | -7.3% | +11.9% |
| 3-Year ReturnCumulative with dividends | +17.5% | +5.8% | +138.8% | +28.3% | +48.8% |
| 5-Year ReturnCumulative with dividends | +41.2% | +7.4% | +135.5% | +44.4% | +57.6% |
| 10-Year ReturnCumulative with dividends | +172.1% | +53.3% | +481.2% | +150.1% | +272.1% |
| CAGR (3Y)Annualised 3-year return | +5.5% | +1.9% | +33.7% | +8.7% | +14.2% |
Risk & Volatility
Evenly matched — JPM and GAIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
GAIN is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than JPM's 0.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs PFLT's 68.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.78x | 0.87x | 0.65x | 0.47x |
| 52-Week HighHighest price in past year | $25.64 | $10.88 | $338.09 | $23.42 | $17.14 |
| 52-Week LowLowest price in past year | $20.78 | $7.42 | $269.72 | $17.40 | $13.11 |
| % of 52W HighCurrent price vs 52-week peak | +86.2% | +68.8% | +96.2% | +77.0% | +86.2% |
| RSI (14)Momentum oscillator 0–100 | 43.4 | 32.3 | 72.1 | 35.6 | 34.8 |
| Avg Volume (50D)Average daily shares traded | 94K | 1.0M | 7.4M | 5.4M | 345K |
Analyst Outlook
Evenly matched — SAR and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SAR as "Hold", PFLT as "Buy", JPM as "Buy", ARCC as "Buy", GAIN as "Hold". Consensus price targets imply 30.3% upside for PFLT (target: $10) vs 4.5% for JPM (target: $340). For income investors, SAR offers the higher dividend yield at 100.00% vs JPM's 1.83%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $9.75 | $339.75 | $19.00 | $17.00 |
| # AnalystsCovering analysts | 11 | 11 | 61 | 32 | 7 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +16.1% | +1.8% | +2.1% | +10.0% |
| Dividend StreakConsecutive years of raises | 5 | 0 | 15 | 0 | 0 |
| Dividend / ShareAnnual DPS | $3303.17 | $1.21 | $5.95 | $0.38 | $1.48 |
| Buyback YieldShare repurchases ÷ mkt cap | +15.1% | 0.0% | +3.8% | 0.0% | 0.0% |
GAIN leads in 1 of 6 categories (Profitability & Efficiency). JPM leads in 1 (Total Returns). 4 tied.
SAR vs PFLT vs JPM vs ARCC vs GAIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SAR or PFLT or JPM or ARCC or GAIN a better buy right now?
For growth investors, Saratoga Investment Corp.
(SAR) is the stronger pick with 1334% revenue growth year-over-year, versus -20. 5% for Gladstone Investment Corporation (GAIN). Gladstone Investment Corporation (GAIN) offers the better valuation at 3. 1x trailing P/E (36. 4x forward), making it the more compelling value choice. Analysts rate PennantPark Floating Rate Capital Ltd. (PFLT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SAR or PFLT or JPM or ARCC or GAIN?
On trailing P/E, Gladstone Investment Corporation (GAIN) is the cheapest at 3.
1x versus JPMorgan Chase & Co. at 16. 2x. On forward P/E, PennantPark Floating Rate Capital Ltd. is actually cheaper at 6. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Saratoga Investment Corp. wins at 0. 75x versus Gladstone Investment Corporation's 1. 21x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SAR or PFLT or JPM or ARCC or GAIN?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +135. 5%, compared to +7. 4% for PennantPark Floating Rate Capital Ltd. (PFLT). Over 10 years, the gap is even starker: JPM returned +481. 2% versus PFLT's +53. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SAR or PFLT or JPM or ARCC or GAIN?
By beta (market sensitivity over 5 years), Gladstone Investment Corporation (GAIN) is the lower-risk stock at 0.
47β versus JPMorgan Chase & Co. 's 0. 87β — meaning JPM is approximately 85% more volatile than GAIN relative to the S&P 500. On balance sheet safety, Gladstone Investment Corporation (GAIN) carries a lower debt/equity ratio of 84% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — SAR or PFLT or JPM or ARCC or GAIN?
By revenue growth (latest reported year), Saratoga Investment Corp.
(SAR) is pulling ahead at 1334% versus -20. 5% for Gladstone Investment Corporation (GAIN). On earnings-per-share growth, the picture is similar: Gladstone Investment Corporation grew EPS 168. 0% year-over-year, compared to -48. 6% for PennantPark Floating Rate Capital Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SAR or PFLT or JPM or ARCC or GAIN?
Gladstone Investment Corporation (GAIN) is the more profitable company, earning 258.
5% net margin versus 0. 1% for Saratoga Investment Corp. — meaning it keeps 258. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAIN leads at 315. 8% versus -0. 1% for SAR. At the gross margin level — before operating expenses — ARCC leads at 75. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SAR or PFLT or JPM or ARCC or GAIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Saratoga Investment Corp. (SAR) is the more undervalued stock at a PEG of 0. 75x versus Gladstone Investment Corporation's 1. 21x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, PennantPark Floating Rate Capital Ltd. (PFLT) trades at 6. 9x forward P/E versus 36. 4x for Gladstone Investment Corporation — 29. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PFLT: 30. 3% to $9. 75.
08Which pays a better dividend — SAR or PFLT or JPM or ARCC or GAIN?
All stocks in this comparison pay dividends.
Saratoga Investment Corp. (SAR) offers the highest yield at 100. 0%, versus 1. 8% for JPMorgan Chase & Co. (JPM).
09Is SAR or PFLT or JPM or ARCC or GAIN better for a retirement portfolio?
For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
47), 10. 0% yield, +272. 1% 10Y return). Both have compounded well over 10 years (GAIN: +272. 1%, PFLT: +53. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SAR and PFLT and JPM and ARCC and GAIN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SAR is a small-cap high-growth stock; PFLT is a small-cap deep-value stock; JPM is a large-cap deep-value stock; ARCC is a mid-cap high-growth stock; GAIN is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.